Efficacy and safety of TCM non-pharmacologic therapy for post-stroke insomnia: a systematic review and network meta-analysis
Sleep and Breathing · 2025-06 · 29 (3)
DOI: 10.1007/s11325-025-03357-5 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Sleep and Breathing, online erschienen am 31.05.2025. Verfasst von Wenyu Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing Keqiao District Traditional Chinese Medcine Hospital Medical Community General Hospital, Shaoxing, 312000, China. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Sleep Initiation and Maintenance Disorders, Stroke. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Traditional Chinese Medicine Administration.
Themen: Schlaf, Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Post-stroke insomnia is a common and frequently occurring disease that has a significant impact on the quality of life of patients. TCM (traditional Chinese medicine) non-pharmacologic therapy is increasingly being used for patients with post-stroke insomnia. The purpose of this study is to evaluate the efficacy and safety of the TCM non-pharmacologic therapy for post-stroke insomnia. METHODS: English and Chinese databases, including PubMed, Web of Science, Cochrane Library, Embase, CNKI, Wanfang, VIP, and SinoMed were retrieved to collect randomized controlled trials (RCTs) comparing the TCM non-pharmacologic therapy with Western medicine in the treatment of post-stroke insomnia. The search was conducted until March 26, 2024. Data analysis was conducted using Stata15.0. RESULTS: This study included a total of 60 RCTs, involving 5 TCM non-pharmacologic therapies and 4,587 patients. The results of the network meta-analysis unveiled that Western medicine combined with massage (SUCRA93.8), Western medicine combined with auricular point sticking (SUCRA80.5), and needle embedding (SUCRA71.5) were the top three measures in clinical efficacy. For improving the Pittsburgh Sleep Quality Index (PSQI), massage (SUCRA86.1) was the most effective, followed by Western medicine combined with auricular point sticking (SUCRA85.4), and Western medicine combined with needle embedding (SUCRA66.4). Regarding adverse reactions, the top three interventions were traditional acupuncture (SUCRA87.7), moxibustion (SUCRA63.2), and Western medicine combined with traditional acupuncture (SUCRA46.0). CONCLUSIONS: TCM non-pharmacologic therapy and Western medicine combined with TCM non-pharmacologic therapy can improve clinical efficacy in post-stroke insomnia, enhance sleep quality, and reduce adverse reactions. Due to the limitations of the included studies, the methodological quality is generally not high, and multicenter, large sample, high-quality RCTs are still needed for validation in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shaoxing Keqiao District Traditional Chinese Medcine Hospital Medical Community General Hospital, Shaoxing, 312000, China.
- Shaoxing Keqiao District Traditional Chinese Medcine Hospital Medical Community General Hospital, Shaoxing, 312000, China. yanchenliu311322@foxmail.com.
Förderung
- Zhejiang Traditional Chinese Medicine Administration
Zitieren
APA
Liu, W., & Jing, R. (2025). Efficacy and safety of TCM non-pharmacologic therapy for post-stroke insomnia: a systematic review and network meta-analysis. Sleep and Breathing, 29(3). https://doi.org/10.1007/s11325-025-03357-5
Vancouver
Liu W, Jing R. Efficacy and safety of TCM non-pharmacologic therapy for post-stroke insomnia: a systematic review and network meta-analysis. Sleep and Breathing. 2025;29(3). doi:10.1007/s11325-025-03357-5
BibTeX
@article{Liu2025,
author = {Liu, Wenyu and Jing, Ruizhi},
title = {Efficacy and safety of TCM non-pharmacologic therapy for post-stroke insomnia: a systematic review and network meta-analysis},
journal = {Sleep and Breathing},
year = {2025},
volume = {29},
number = {3},
doi = {10.1007/s11325-025-03357-5}
}
EUVIMED